Literature DB >> 8507104

Micronucleus incidence and hematological effects in bullfrog tadpoles (Rana catesbeiana) exposed to 2-acetylaminofluorene and 2-aminofluorene.

P W Krauter1.   

Abstract

The micronucleus technique used with Rana catesbeiana tadpoles is useful for the evaluation of aromatic amine toxicity. When exposed to increasing concentrations of the aromatic amine 2-acetylaminofluorene (2-AAF 1 x 10(-8) M to 5 x 10(-5) M), R. catesbeiana tadpoles responded with an increasing frequency of micronuclei (MN) in the peripheral blood. Micronuclei increased fourfold with the 5 x 10(-5) M 2-AAF exposure. Micronuclei frequency significantly increased with concentrations as low as 5 x 10(-8) M. The time from initial mutagen exposure to the time of maximum number of MN present in the peripheral blood occurred at two separate times: 2 d and 14 d after exposure. The occurrence of two MN frequency peaks may be due to the presence of two erythrocyte populations from two hemopoietic sources (liver and kidneys) in young tadpoles. The occurrence of immature erythrocytes, as well as general degenerative changes [such as fragmentation (schistocytosis)] in the erythrocytes and vacuolated cytoplasms suggested 2-AAF may contribute to hemolytic anemia effects. 2-AAF also increased the frequency of rubricytes found in the peripheral blood, but had no significant effect on the hematocrit values of animals exposed to concentrations up to 1 x 10(-5) M. The tadpoles may have been producing rubricytes to replace the damaged red blood cells (RBCs). The direct-acting mutagen 2-aminofluorene (2-AF) was considerably more toxic to peripheral RBCs than the indirect-acting 2-AAF.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507104     DOI: 10.1007/BF01146167

Source DB:  PubMed          Journal:  Arch Environ Contam Toxicol        ISSN: 0090-4341            Impact factor:   2.804


  20 in total

1.  Radiation-induced micronuclei in peripheral erythrocytes of Rana catesbeiana: an aquatic animal model for in vivo genotoxicity studies.

Authors:  P W Krauter; S L Anderson; F L Harrison
Journal:  Environ Mol Mutagen       Date:  1987       Impact factor: 3.216

2.  The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene.

Authors:  S S Thorgeirsson; D J Jollow; H A Sasame; I Green; J R Mitchell
Journal:  Mol Pharmacol       Date:  1973-05       Impact factor: 4.436

Review 3.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture.

Authors:  J A Miller
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

4.  Acute toxicities and hematological effects of two substituted naphthoquinones in channel catfish.

Authors:  A A Andaya; R T Di Giulio
Journal:  Arch Environ Contam Toxicol       Date:  1987-03       Impact factor: 2.804

5.  Two erythropietic microenvironments and two larval red cell lines in bullfrog tadpoles.

Authors:  R H Broyles; G M Johnson; P B Maples; G R Kindell
Journal:  Dev Biol       Date:  1981-01-30       Impact factor: 3.582

6.  Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test.

Authors:  J T MacGregor; C M Wehr; D H Gould
Journal:  Environ Mutagen       Date:  1980

7.  Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method.

Authors:  J A Heddle; C B Lue; E F Saunders; R D Benz
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

8.  Statistical analysis of the micronucleus test.

Authors:  G E Amphlett; G F Delow
Journal:  Mutat Res       Date:  1984-09       Impact factor: 2.433

9.  Induction of nuclear anomalies (micronuclei) in the peripheral blood erythrocytes of the eastern mudminnow Umbra pygmaea by ethyl methanesulphonate.

Authors:  R N Hooftman; W K de Raat
Journal:  Mutat Res       Date:  1982-04       Impact factor: 2.433

10.  Analysis of hemoglobin as a dose monitor for alkylating and arylating agents.

Authors:  H G Neumann
Journal:  Arch Toxicol       Date:  1984-11       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.